Move On to Bring Medical Devices Sector Under D&C Act
The Planning Commission has recommended for amendment in the Drugs and Cosmetics (D&C) Act to ensure that the devices are safe and have least adverse reaction
The Planning Commission has recommended for amendment in the Drugs and Cosmetics (D&C) Act to ensure that the devices are safe and have least adverse reaction
Over 50,000 chemists across Maharashtra are threatening to go on strike for three days starting October 16, putting the spotlight […]
After attending the 5th Asia Pacific Conference of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) at Taipei in […]
A new recommendation has come in for the Indian drug companies. Most Indian drug companies that were penalised for violating […]
Gujarat perhaps going to be the next hub of Indian healthcare enterprise. After Vicks and Colgate Palmolive, US-based Abbott Laboratories […]
Certain barriers are preventing physicians and pharmacies from realizing the full benefit of electronic prescribing systems, according to a study […]
Dr Ajay Singla, Additional Secretary, Health & Family Welfare, Government of NCT of Delhi and CEO, Aapka Swasthya Bima Yojana is one of the most dynamic healthcare leaders and visionaries in the country.
GetRxConnected.com aims to persuade physicians to switch from paper-based medical prescriptions to e-prescribing, claiming it can reduce errors and save lives.
Pharmaceutical firm Merck Ltd announced recently that it has partnered with software firm Cirrius Wireless Technologies for providing mobile-based solution, marketing network and activation system (MANAS) to its sales representatives across the country.
Two new pilots are underway to offer pharmacy personal health records (PHRs) in Germany. Both are based on a PHR including details of current medication and offer patients the potential to offer prescription ordering online.
In the next three years, India would move towards setting up a drug regulatory authority on the model of the US FDA, the country
Cellworks Research India, the Bangalore-based research and development (R&D) wing of Cellworks Group Inc (California-headquartered company), has assisted Chennai-based Orchid Chemicals and Pharmaceuticals by providing system biology technology in carrying out ongoing New Chemical Entity (NCE) research programme.
US-based private equity fund Citi Venture Capital (CVC) has picked up nearly 30% stake in Mumbai-based bulk drug maker Unimark Remedies for INR 113 crore. The transaction, one of the largest investments in the pharma sector in 2007 and CVC